Jessica Jones-Carson
Concepts (297)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nitric Oxide | 16 | 2020 | 886 | 2.140 |
Why?
| Salmonella typhimurium | 15 | 2024 | 176 | 1.330 |
Why?
| Salmonella | 4 | 2020 | 56 | 1.070 |
Why?
| Burkholderia pseudomallei | 3 | 2014 | 10 | 0.950 |
Why?
| Salmonella enterica | 5 | 2016 | 54 | 0.870 |
Why?
| Bacterial Proteins | 16 | 2020 | 826 | 0.820 |
Why?
| Cytokinesis | 1 | 2020 | 48 | 0.650 |
Why?
| Bacillus subtilis | 1 | 2020 | 65 | 0.650 |
Why?
| Cytochrome d Group | 1 | 2016 | 2 | 0.550 |
Why?
| Cytochrome b Group | 1 | 2016 | 19 | 0.550 |
Why?
| Candidiasis | 8 | 2000 | 53 | 0.510 |
Why?
| Escherichia coli | 1 | 2020 | 770 | 0.500 |
Why?
| Interferon-gamma | 8 | 2014 | 761 | 0.480 |
Why?
| Macrophages | 7 | 2014 | 1463 | 0.480 |
Why?
| Imipenem | 1 | 2014 | 15 | 0.470 |
Why?
| Anti-Bacterial Agents | 3 | 2014 | 1667 | 0.460 |
Why?
| Oxygen | 2 | 2016 | 901 | 0.440 |
Why?
| Candida albicans | 7 | 2000 | 52 | 0.420 |
Why?
| NADPH Oxidases | 6 | 2024 | 108 | 0.410 |
Why?
| Salmonella Infections | 4 | 2013 | 52 | 0.400 |
Why?
| Burkholderia mallei | 2 | 2011 | 7 | 0.390 |
Why?
| Gene Expression Regulation, Bacterial | 5 | 2018 | 322 | 0.380 |
Why?
| Iron-Sulfur Proteins | 2 | 2008 | 26 | 0.360 |
Why?
| Energy Metabolism | 1 | 2016 | 836 | 0.360 |
Why?
| Immunologic Memory | 2 | 2007 | 339 | 0.350 |
Why?
| Macrophages, Peritoneal | 10 | 2011 | 90 | 0.330 |
Why?
| Phagosomes | 4 | 2020 | 42 | 0.320 |
Why?
| Mice | 40 | 2024 | 16579 | 0.310 |
Why?
| Gastric Mucosa | 2 | 2007 | 50 | 0.310 |
Why?
| Proton-Motive Force | 2 | 2020 | 6 | 0.290 |
Why?
| Phagocytes | 3 | 2024 | 96 | 0.270 |
Why?
| Animals | 41 | 2024 | 34501 | 0.250 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2005 | 334 | 0.240 |
Why?
| Oxygen Consumption | 2 | 2020 | 675 | 0.240 |
Why?
| Endotoxemia | 1 | 2005 | 83 | 0.230 |
Why?
| Salmonella Infections, Animal | 7 | 2010 | 38 | 0.230 |
Why?
| Repressor Proteins | 3 | 2013 | 400 | 0.230 |
Why?
| Membrane Proteins | 3 | 2007 | 1108 | 0.230 |
Why?
| T-Lymphocytes | 4 | 2004 | 1922 | 0.230 |
Why?
| Immunity, Innate | 8 | 2020 | 803 | 0.220 |
Why?
| Mice, Knockout | 13 | 2008 | 2752 | 0.210 |
Why?
| Mice, Inbred C57BL | 18 | 2018 | 5257 | 0.210 |
Why?
| Methionine | 1 | 2024 | 157 | 0.210 |
Why?
| Shock, Septic | 1 | 2005 | 206 | 0.210 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2005 | 374 | 0.200 |
Why?
| Guanosine Tetraphosphate | 2 | 2020 | 4 | 0.200 |
Why?
| Immunocompromised Host | 3 | 1999 | 195 | 0.190 |
Why?
| Anaerobiosis | 4 | 2024 | 58 | 0.190 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2007 | 840 | 0.180 |
Why?
| Genomic Islands | 2 | 2018 | 7 | 0.180 |
Why?
| Aconitate Hydratase | 2 | 2012 | 17 | 0.170 |
Why?
| T-Lymphocyte Subsets | 3 | 2000 | 410 | 0.170 |
Why?
| Ligases | 1 | 2020 | 30 | 0.170 |
Why?
| Pyrophosphatases | 1 | 2020 | 21 | 0.170 |
Why?
| Cytoskeletal Proteins | 1 | 2020 | 142 | 0.160 |
Why?
| Stress, Physiological | 3 | 2018 | 412 | 0.160 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1999 | 99 | 0.160 |
Why?
| Electron Transport Chain Complex Proteins | 2 | 2016 | 19 | 0.160 |
Why?
| Immunity, Mucosal | 3 | 2004 | 87 | 0.150 |
Why?
| Virulence Factors | 3 | 2018 | 153 | 0.150 |
Why?
| Nitrosative Stress | 1 | 2018 | 4 | 0.150 |
Why?
| Escherichia coli Infections | 1 | 1999 | 106 | 0.150 |
Why?
| Immunologic Deficiency Syndromes | 2 | 1995 | 62 | 0.150 |
Why?
| Oxidative Stress | 4 | 2014 | 1188 | 0.140 |
Why?
| Microbial Viability | 4 | 2018 | 83 | 0.140 |
Why?
| Oxidation-Reduction | 3 | 2016 | 1001 | 0.140 |
Why?
| Regulon | 3 | 2018 | 35 | 0.140 |
Why?
| Nucleotides | 1 | 2018 | 117 | 0.140 |
Why?
| Urinary Tract Infections | 1 | 1999 | 150 | 0.140 |
Why?
| Macrophage Activation | 6 | 2008 | 186 | 0.130 |
Why?
| Oxidoreductases | 1 | 2016 | 90 | 0.130 |
Why?
| Candidiasis, Vulvovaginal | 1 | 1995 | 4 | 0.120 |
Why?
| Candidiasis, Oral | 1 | 1995 | 17 | 0.120 |
Why?
| B-Lymphocytes | 3 | 1999 | 820 | 0.120 |
Why?
| Transcription Factors | 4 | 2018 | 1631 | 0.120 |
Why?
| Transforming Growth Factor beta | 3 | 2005 | 448 | 0.110 |
Why?
| Germ-Free Life | 4 | 1997 | 33 | 0.110 |
Why?
| Microbial Sensitivity Tests | 2 | 2012 | 335 | 0.100 |
Why?
| Reactive Oxygen Species | 4 | 2012 | 579 | 0.100 |
Why?
| Mice, Mutant Strains | 6 | 2007 | 292 | 0.100 |
Why?
| Neutrophils | 4 | 1999 | 1188 | 0.100 |
Why?
| Nitroso Compounds | 1 | 2012 | 5 | 0.100 |
Why?
| Melioidosis | 1 | 2012 | 5 | 0.100 |
Why?
| Oxidants | 1 | 2012 | 106 | 0.100 |
Why?
| Nitric Oxide Donors | 1 | 2012 | 18 | 0.100 |
Why?
| Superoxides | 4 | 2008 | 196 | 0.100 |
Why?
| Spermine | 1 | 2012 | 28 | 0.100 |
Why?
| Membrane Glycoproteins | 3 | 2008 | 466 | 0.100 |
Why?
| Respiratory Burst | 3 | 2008 | 15 | 0.100 |
Why?
| Receptors, Cell Surface | 2 | 2004 | 371 | 0.100 |
Why?
| Culture Media | 1 | 2012 | 167 | 0.090 |
Why?
| Alanine Racemase | 1 | 2011 | 2 | 0.090 |
Why?
| DNA-Binding Proteins | 2 | 2010 | 1415 | 0.090 |
Why?
| Glutathione | 1 | 2012 | 334 | 0.090 |
Why?
| Nitric Oxide Synthase Type II | 5 | 2013 | 167 | 0.090 |
Why?
| Sulfhydryl Compounds | 1 | 2012 | 185 | 0.090 |
Why?
| Cells, Cultured | 4 | 2014 | 4008 | 0.090 |
Why?
| Virulence | 4 | 2020 | 254 | 0.080 |
Why?
| Hypoxia | 1 | 2016 | 1031 | 0.080 |
Why?
| Mice, Inbred BALB C | 6 | 2002 | 1229 | 0.080 |
Why?
| Nitric Oxide Synthase | 3 | 2000 | 232 | 0.080 |
Why?
| Disease Models, Animal | 4 | 2020 | 3943 | 0.070 |
Why?
| NADPH Dehydrogenase | 1 | 2008 | 8 | 0.070 |
Why?
| Trans-Activators | 1 | 2010 | 381 | 0.070 |
Why?
| Peroxiredoxins | 1 | 2008 | 24 | 0.070 |
Why?
| Spleen | 3 | 2000 | 513 | 0.070 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2005 | 1190 | 0.070 |
Why?
| Sphingomyelin Phosphodiesterase | 1 | 2007 | 18 | 0.070 |
Why?
| Nitrogen Oxides | 1 | 2007 | 52 | 0.070 |
Why?
| Lipopolysaccharides | 4 | 2005 | 856 | 0.070 |
Why?
| Survival Analysis | 2 | 2010 | 1265 | 0.070 |
Why?
| Hydrogen Peroxide | 1 | 2008 | 308 | 0.070 |
Why?
| Organ Specificity | 1 | 2007 | 291 | 0.070 |
Why?
| Genes, Bacterial | 4 | 2011 | 158 | 0.060 |
Why?
| Models, Genetic | 1 | 2008 | 590 | 0.060 |
Why?
| Anti-Infective Agents | 1 | 2008 | 225 | 0.060 |
Why?
| Mutation | 4 | 2011 | 3692 | 0.060 |
Why?
| Phagocytosis | 3 | 2004 | 364 | 0.060 |
Why?
| Kupffer Cells | 1 | 2004 | 49 | 0.060 |
Why?
| Respiration | 1 | 2024 | 190 | 0.050 |
Why?
| Leptin | 2 | 2004 | 218 | 0.050 |
Why?
| Molecular Sequence Data | 3 | 2011 | 2818 | 0.050 |
Why?
| Stomach | 2 | 2000 | 109 | 0.050 |
Why?
| Sigma Factor | 1 | 2002 | 40 | 0.050 |
Why?
| Colitis | 1 | 2004 | 240 | 0.050 |
Why?
| Disease Susceptibility | 2 | 2004 | 334 | 0.050 |
Why?
| Models, Biological | 1 | 2008 | 1693 | 0.040 |
Why?
| ADP Ribose Transferases | 1 | 2000 | 8 | 0.040 |
Why?
| Guanosine Pentaphosphate | 1 | 2020 | 3 | 0.040 |
Why?
| Cell Survival | 2 | 2020 | 1077 | 0.040 |
Why?
| Hydroxides | 1 | 2000 | 26 | 0.040 |
Why?
| Humans | 7 | 2024 | 128524 | 0.040 |
Why?
| Colony Count, Microbial | 1 | 2000 | 116 | 0.040 |
Why?
| Immunity, Cellular | 3 | 1999 | 267 | 0.040 |
Why?
| CD18 Antigens | 1 | 1999 | 26 | 0.040 |
Why?
| Gram-Positive Bacteria | 1 | 2020 | 45 | 0.040 |
Why?
| Liver | 4 | 2004 | 1827 | 0.040 |
Why?
| Gram-Negative Bacteria | 1 | 2020 | 69 | 0.040 |
Why?
| Mice, Inbred MRL lpr | 1 | 1999 | 38 | 0.040 |
Why?
| Transcription Factor RelA | 1 | 2020 | 82 | 0.040 |
Why?
| Gene Deletion | 2 | 2011 | 372 | 0.040 |
Why?
| Bacterial Toxins | 1 | 2000 | 106 | 0.040 |
Why?
| Receptors, Interleukin | 1 | 1999 | 42 | 0.040 |
Why?
| Mucous Membrane | 1 | 2000 | 120 | 0.040 |
Why?
| Intestinal Diseases | 1 | 1999 | 35 | 0.040 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 2000 | 134 | 0.040 |
Why?
| Interleukin-18 | 1 | 2000 | 237 | 0.040 |
Why?
| Type III Secretion Systems | 1 | 2018 | 11 | 0.040 |
Why?
| Antioxidants | 1 | 2002 | 543 | 0.040 |
Why?
| Esophagus | 1 | 2000 | 248 | 0.040 |
Why?
| Mice, Inbred C3H | 2 | 2010 | 274 | 0.040 |
Why?
| Antigens, Fungal | 1 | 1997 | 26 | 0.030 |
Why?
| beta 2-Microglobulin | 1 | 1996 | 47 | 0.030 |
Why?
| Interleukin-10 | 1 | 1999 | 299 | 0.030 |
Why?
| Wound Healing | 1 | 1999 | 310 | 0.030 |
Why?
| Antigens, CD | 1 | 1999 | 479 | 0.030 |
Why?
| Lymphocyte Activation | 2 | 1999 | 1098 | 0.030 |
Why?
| Mice, Nude | 2 | 1995 | 682 | 0.030 |
Why?
| Intestines | 1 | 1999 | 345 | 0.030 |
Why?
| Nitrates | 1 | 1996 | 87 | 0.030 |
Why?
| Immunophenotyping | 1 | 1997 | 312 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 2011 | 1019 | 0.030 |
Why?
| Antifungal Agents | 1 | 1996 | 125 | 0.030 |
Why?
| Amino Acid Oxidoreductases | 1 | 1995 | 18 | 0.030 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2000 | 701 | 0.030 |
Why?
| Specific Pathogen-Free Organisms | 1 | 1995 | 60 | 0.030 |
Why?
| Histocompatibility Antigens Class I | 1 | 1996 | 195 | 0.030 |
Why?
| Kidney | 2 | 2000 | 1305 | 0.030 |
Why?
| Recombinant Proteins | 2 | 1995 | 1284 | 0.030 |
Why?
| Lymphocyte Depletion | 1 | 1995 | 129 | 0.030 |
Why?
| NADPH Oxidase 2 | 2 | 2008 | 38 | 0.030 |
Why?
| Immunocompetence | 1 | 1994 | 43 | 0.030 |
Why?
| Analysis of Variance | 2 | 2013 | 1271 | 0.030 |
Why?
| Cell Separation | 1 | 1995 | 313 | 0.030 |
Why?
| Arginine | 1 | 1995 | 258 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 1199 | 0.030 |
Why?
| Nitrosation | 1 | 2012 | 8 | 0.030 |
Why?
| Reactive Nitrogen Species | 1 | 2012 | 22 | 0.030 |
Why?
| Microscopy, Electron | 2 | 2005 | 417 | 0.020 |
Why?
| Molecular Weight | 1 | 2012 | 331 | 0.020 |
Why?
| Gene Expression Profiling | 2 | 2011 | 1687 | 0.020 |
Why?
| Periodic Acid | 1 | 2011 | 1 | 0.020 |
Why?
| Base Sequence | 1 | 1995 | 2134 | 0.020 |
Why?
| Flow Cytometry | 1 | 1995 | 1141 | 0.020 |
Why?
| Microscopy, Fluorescence | 2 | 2005 | 402 | 0.020 |
Why?
| Microarray Analysis | 1 | 2011 | 121 | 0.020 |
Why?
| Operon | 1 | 2010 | 63 | 0.020 |
Why?
| Sequence Alignment | 1 | 2011 | 330 | 0.020 |
Why?
| Alanine | 1 | 2011 | 141 | 0.020 |
Why?
| Brain | 2 | 2000 | 2618 | 0.020 |
Why?
| Chromatin Immunoprecipitation | 1 | 2010 | 130 | 0.020 |
Why?
| Gene Knockout Techniques | 1 | 2010 | 109 | 0.020 |
Why?
| Genetic Markers | 1 | 2011 | 339 | 0.020 |
Why?
| Plasmids | 1 | 2011 | 357 | 0.020 |
Why?
| Metabolic Networks and Pathways | 1 | 2011 | 175 | 0.020 |
Why?
| Genetic Loci | 1 | 2011 | 274 | 0.020 |
Why?
| Inflammation | 2 | 1999 | 2664 | 0.020 |
Why?
| Mice, SCID | 2 | 2004 | 345 | 0.020 |
Why?
| Immunity | 1 | 2010 | 131 | 0.020 |
Why?
| Time Factors | 1 | 2000 | 6503 | 0.020 |
Why?
| DNA, Bacterial | 1 | 2010 | 324 | 0.020 |
Why?
| Peroxynitrous Acid | 1 | 2008 | 14 | 0.020 |
Why?
| Apoptosis | 1 | 1997 | 2437 | 0.020 |
Why?
| Flavoproteins | 1 | 2007 | 8 | 0.020 |
Why?
| Hemeproteins | 1 | 2007 | 6 | 0.020 |
Why?
| Drug Resistance, Microbial | 1 | 2008 | 63 | 0.020 |
Why?
| Succinate Dehydrogenase | 1 | 2007 | 43 | 0.020 |
Why?
| Concanavalin A | 2 | 2000 | 75 | 0.020 |
Why?
| Gangliosides | 1 | 2007 | 19 | 0.020 |
Why?
| Guanidines | 2 | 1999 | 36 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2011 | 2041 | 0.020 |
Why?
| Host-Pathogen Interactions | 1 | 2010 | 348 | 0.020 |
Why?
| Sphingolipids | 1 | 2007 | 69 | 0.020 |
Why?
| Interleukin-4 | 2 | 1999 | 213 | 0.020 |
Why?
| Cytosol | 1 | 2007 | 213 | 0.020 |
Why?
| Ceramides | 1 | 2007 | 104 | 0.020 |
Why?
| Antibody Formation | 2 | 1999 | 287 | 0.020 |
Why?
| Acute Disease | 2 | 1999 | 968 | 0.020 |
Why?
| Escherichia coli Proteins | 1 | 2007 | 177 | 0.020 |
Why?
| DNA, Complementary | 1 | 2005 | 267 | 0.010 |
Why?
| Female | 7 | 2011 | 68127 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 756 | 0.010 |
Why?
| Receptors, Leptin | 1 | 2004 | 23 | 0.010 |
Why?
| Mice, Congenic | 1 | 2004 | 22 | 0.010 |
Why?
| Lymphocyte Transfusion | 1 | 2004 | 20 | 0.010 |
Why?
| Protein Binding | 1 | 2010 | 2097 | 0.010 |
Why?
| Intestinal Mucosa | 2 | 1999 | 575 | 0.010 |
Why?
| RNA, Bacterial | 1 | 2005 | 182 | 0.010 |
Why?
| Leukocyte Common Antigens | 1 | 2004 | 81 | 0.010 |
Why?
| Chemokines, CXC | 1 | 2004 | 68 | 0.010 |
Why?
| Neutrophil Infiltration | 1 | 2004 | 97 | 0.010 |
Why?
| Cytotoxicity, Immunologic | 1 | 2004 | 218 | 0.010 |
Why?
| Th1 Cells | 1 | 2004 | 136 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2011 | 3023 | 0.010 |
Why?
| Corticosterone | 1 | 2004 | 214 | 0.010 |
Why?
| Toll-Like Receptors | 1 | 2004 | 179 | 0.010 |
Why?
| Aerobiosis | 1 | 2002 | 23 | 0.010 |
Why?
| Toll-Like Receptor 4 | 1 | 2004 | 263 | 0.010 |
Why?
| Exotoxins | 1 | 2000 | 15 | 0.010 |
Why?
| Peroxides | 1 | 2000 | 18 | 0.010 |
Why?
| Cerium | 1 | 2000 | 14 | 0.010 |
Why?
| Vacuoles | 1 | 2000 | 36 | 0.010 |
Why?
| Mice, Obese | 1 | 2000 | 57 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 779 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2000 | 150 | 0.010 |
Why?
| 3-Phosphoshikimate 1-Carboxyvinyltransferase | 1 | 1999 | 1 | 0.010 |
Why?
| Luminol | 1 | 1999 | 1 | 0.010 |
Why?
| Receptors, Interleukin-8A | 1 | 1999 | 6 | 0.010 |
Why?
| Tyrosine | 1 | 2000 | 216 | 0.010 |
Why?
| Transplantation Chimera | 1 | 1999 | 54 | 0.010 |
Why?
| Fimbriae, Bacterial | 1 | 1999 | 28 | 0.010 |
Why?
| Alkyl and Aryl Transferases | 1 | 1999 | 53 | 0.010 |
Why?
| Indicators and Reagents | 1 | 1999 | 104 | 0.010 |
Why?
| Lymphocyte Cooperation | 1 | 1999 | 49 | 0.010 |
Why?
| Injections, Intravenous | 1 | 1999 | 193 | 0.010 |
Why?
| Transplantation Immunology | 1 | 1999 | 33 | 0.010 |
Why?
| Luminescent Measurements | 1 | 1999 | 78 | 0.010 |
Why?
| Mutagenesis | 1 | 1999 | 181 | 0.010 |
Why?
| Biological Transport | 1 | 1999 | 394 | 0.010 |
Why?
| Chronic Disease | 1 | 2004 | 1701 | 0.010 |
Why?
| Bone Marrow Transplantation | 1 | 1999 | 268 | 0.010 |
Why?
| Major Histocompatibility Complex | 1 | 1999 | 229 | 0.010 |
Why?
| Stomach Ulcer | 1 | 1997 | 11 | 0.010 |
Why?
| Bacteremia | 1 | 1999 | 188 | 0.010 |
Why?
| Ulcer | 1 | 1997 | 29 | 0.010 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 1999 | 626 | 0.010 |
Why?
| Hyperplasia | 1 | 1997 | 170 | 0.010 |
Why?
| Disease Progression | 1 | 2004 | 2603 | 0.010 |
Why?
| Opsonin Proteins | 1 | 1996 | 24 | 0.010 |
Why?
| Digestive System Diseases | 1 | 1996 | 25 | 0.010 |
Why?
| Glucans | 1 | 1996 | 24 | 0.010 |
Why?
| Immune Tolerance | 1 | 1999 | 345 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1997 | 402 | 0.010 |
Why?
| Inflammation Mediators | 1 | 1999 | 500 | 0.010 |
Why?
| Hematopoietic Stem Cells | 1 | 1999 | 377 | 0.010 |
Why?
| Cytokines | 1 | 2004 | 1985 | 0.010 |
Why?
| Longevity | 1 | 1997 | 149 | 0.010 |
Why?
| Male | 5 | 2004 | 62883 | 0.010 |
Why?
| omega-N-Methylarginine | 1 | 1995 | 26 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2004 | 2266 | 0.010 |
Why?
| Infusions, Intravenous | 1 | 1996 | 384 | 0.010 |
Why?
| Killer Cells, Natural | 1 | 1999 | 425 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 811 | 0.010 |
Why?
| Nitroprusside | 1 | 1995 | 66 | 0.010 |
Why?
| Homeostasis | 1 | 1999 | 605 | 0.010 |
Why?
| Nitrites | 1 | 1995 | 81 | 0.010 |
Why?
| Thioglycolates | 1 | 1994 | 3 | 0.010 |
Why?
| Genotype | 1 | 1999 | 1831 | 0.010 |
Why?
| Blotting, Western | 1 | 1996 | 1168 | 0.010 |
Why?
| Chemotaxis | 1 | 1994 | 130 | 0.010 |
Why?
| Pneumonia | 1 | 1999 | 599 | 0.010 |
Why?
| Superoxide Dismutase | 1 | 1994 | 322 | 0.010 |
Why?
| Hot Temperature | 1 | 1994 | 362 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 1995 | 1943 | 0.010 |
Why?
| Signal Transduction | 1 | 2004 | 4829 | 0.010 |
Why?
| Aging | 1 | 1999 | 1770 | 0.000 |
Why?
| Gene Expression Regulation | 1 | 1996 | 2506 | 0.000 |
Why?
|
|
Jones-Carson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|